Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 Trials

BACKGROUND: Outcomes for patients in the second-line setting of advanced urothelial carcinoma (UC) are dismal. The recognized prognostic factors in this context are Eastern Cooperative Oncology Group (ECOG) performance status (PS) >0, hemoglobin level (Hb) <10 g/dl, and liver metastasis (LM)....

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Sonpavde, Guru, Pond, Gregory R., Fougeray, Ronan, Choueiri, Toni K., Qu, Angela Q., Vaughn, David J., Niegisch, Guenter, Albers, Peter, James, Nicholas D., Wong, Yu-Ning, Ko, Yoo-Joung, Sridhar, Srikala S., Galsky, Matthew D., Petrylak, Daniel P., Vaishampayan, Ulka N., Khan, Awais, Vogelzang, Nicholas J., Beer, Tomasz M., Stadler, Walter M., O’Donnell, Peter H., Sternberg, Cora N., Rosenberg, Jonathan E., Bellmunt, Joaquim
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4127896/
https://ncbi.nlm.nih.gov/pubmed/23206856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2012.11.042
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items